Managed Care

 

Single-source drugs get formulary preference

MANAGED CARE March 2001. © MediMedia USA
News and Commentary

Single-source drugs get formulary preference

MANAGED CARE March 2001. ©MediMedia USA

Managed care organizations often place costly new drugs on a formulary's priciest tier, but products for which substitutes do not exist often are made available at lower copayment levels. Average copayments for single-source, brand-name products are considerably lower than those for branded compounds available from multiple sources. Interpretation suggests that employers and MCOs recognize that access to products for which substitutes are unavailable — particularly when they can save lives or reduce morbidity — is important, even though the relative cost of most single-source products is high.

Average copayments, by product source, 1999

SOURCE: WYETH-AYERST PRESCRIPTION DRUG BENEFIT COST AND PLAN DESIGN SURVEY, COPYRIGHT 2000, PHARMACY BENEFIT MANAGEMENT INSTITUTE, TEMPE, ARIZ.

Meetings

2014 Annual HEDIS® and Star Ratings Symposium Nashville, TN November 3–4, 2014
PCMH & Shared Savings ACO Leadership Summit Nashville, TN November 3–4, 2014
Medicare Risk Adjustment, Revenue Management, & Star Ratings Fort Lauderdale, FL November 12–14, 2014
World Orphan Drug Congress Europe 2014 Brussels, Belgium November 12–14, 2014
Healthcare Chief Medical Officer Forum Alexandria, VA November 13–14, 2014
Home Care Leadership Summit Atlanta, GA November 17–18, 2014
6th Semi-Annual Diagnostic Coverage and Reimbursement Conference Boston December 4–5, 2014
Customer Analytics & Engagement in Health Insurance Chicago December 4–5, 2014
Pharmaceutical and Biotech Clinical Quality Assurance Conference Alexandria, VA December 4–5, 2014
9th Semi-Annual Medical Device Coverage and Reimbursement Conference San Diego December 5, 2014
8th Annual Medical Device Clinical Trials Conference Chicago December 8–9, 2014
HealthIMPACT Southeast Tampa, FL January 23, 2015